However, the aberrant activation or mutation in CTNNB1 is associated with several diseases as well as cancers, such as colon cancer, pancreatic cancer, lung cancer, ovarian cancer, hepatoblastoma, and thymoma [11, 12]. Here, CTNNB1 is linked to cancer.